| Patent | Date |
|---|
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
Grant 11,421,031 - Koenig , et al. August 23, 2 | 2022-08-23 |
Combination Therapy for the Treatment of Cancer
App 20220204625 - Vasselli; James ; et al. | 2022-06-30 |
Combination Therapy for the Treatment of Cancer
App 20220041725 - Wigginton; Jon Marc ; et al. | 2022-02-10 |
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof
App 20220041714 - Bonvini; Ezio ; et al. | 2022-02-10 |
Combination therapy for the treatment of cancer
Grant 11,174,315 - Vasselli , et al. November 16, 2 | 2021-11-16 |
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof
Grant 11,098,119 - Bonvini , et al. August 24, 2 | 2021-08-24 |
Optimized gp41-Binding Molecules and Uses Thereof
App 20210246194 - Lam; Chia-Ying Kao ; et al. | 2021-08-12 |
Combination therapy for the treatment of cancer
Grant 11,078,279 - Wigginton , et al. August 3, 2 | 2021-08-03 |
LAG-3-binding molecules and methods of use thereof
Grant 11,072,653 - La Motte-Mohs , et al. July 27, 2 | 2021-07-27 |
LAG-3-Binding Molecules and Methods of Use Thereof
App 20210206851 - La Motte-Mohs; Ross ; et al. | 2021-07-08 |
Methods Of Using Bispecific Molecules Having Immunoreactivity With Pd-1 And Ctla-4
App 20210130470 - JOHNSON; Leslie S. ; et al. | 2021-05-06 |
Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
App 20210095021 - Koenig; Scott ; et al. | 2021-04-01 |
Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof
Grant 10,954,301 - Johnson , et al. March 23, 2 | 2021-03-23 |
Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting
App 20200392245 - Stavenhagen; Jeffrey B. ; et al. | 2020-12-17 |
Bispecific Molecules Comprising An Hiv-1 Envelope Targeting Arm
App 20200354439 - HAYNES; Barton F. ; et al. | 2020-11-12 |
Combination Therapy
App 20200255524 - Kind Code | 2020-08-13 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
Grant 10,730,947 - Koenig , et al. | 2020-08-04 |
Pd-1-binding Molecules And Methods Of Use Thereof
App 20200231675 - Shah; Kalpana ; et al. | 2020-07-23 |
Bispecific molecules comprising an HIV-1 envelope targeting arm
Grant 10,717,778 - Haynes , et al. | 2020-07-21 |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting
Grant 10,711,069 - Stavenhagen , et al. | 2020-07-14 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof
App 20200216537 - Johnson; Leslie S. ; et al. | 2020-07-09 |
FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
App 20200131265 - Koenig; Scott ; et al. | 2020-04-30 |
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof
Grant 10,633,443 - Johnson , et al. | 2020-04-28 |
PD-1-binding molecules and methods of use thereof
Grant 10,577,422 - Shah , et al. | 2020-03-03 |
Combination Therapy for the Treatment of Cancer
App 20190389952 - Vasselli; James ; et al. | 2019-12-26 |
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof
App 20190169292 - Bonvini; Ezio ; et al. | 2019-06-06 |
Bispecific Molecules Having Immunoreactivity with PD-1 and CTLA-4, and Methods of Use Thereof
App 20190161548 - Johnson; Leslie S. ; et al. | 2019-05-30 |
PD-1-Binding Molecules and Methods of Use Thereof
App 20190127467 - Shah; Kalpana ; et al. | 2019-05-02 |
LAG-3-Binding Molecules and Methods of Use Thereof
App 20190085075 - La Motte-Mohs; Ross ; et al. | 2019-03-21 |
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof
Grant 10,160,806 - Bonvini , et al. Dec | 2018-12-25 |
Combination Therapy for the Treatment of Cancer
App 20180298100 - Wigginton; Jon Marc ; et al. | 2018-10-18 |
Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
App 20180155423 - Koenig; Scott ; et al. | 2018-06-07 |
Bispecific Molecules Comprising An Hiv-1 Envelope Targeting Arm
App 20180148497 - HAYNES; Barton F. ; et al. | 2018-05-31 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
Grant 9,908,938 - Koenig , et al. March 6, 2 | 2018-03-06 |
Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting
App 20180009902 - Stavenhagen; Jeffrey B. ; et al. | 2018-01-11 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof
App 20170247452 - Johnson; Leslie S. ; et al. | 2017-08-31 |
Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting
Grant 9,708,408 - Stavenhagen , et al. July 18, 2 | 2017-07-18 |
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof
App 20170198037 - Bonvini; Ezio ; et al. | 2017-07-13 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof
App 20170157251 - Bonvini; Ezio ; et al. | 2017-06-08 |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
Grant 9,487,587 - Koenig November 8, 2 | 2016-11-08 |
HER2/neu-Specific Antibodies and Methods of Using Same
App 20160257761 - Koenig; Scott ; et al. | 2016-09-08 |
Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity
App 20160046714 - Koenig; Scott ; et al. | 2016-02-18 |
Bispecific Molecules That are Immunoreactive with Immune Effector Cells That Express an Activating Receptor and an Antigen Expressed by a Cell Infected by a Virus and Uses Thereof
App 20160017038 - Koenig; Scott | 2016-01-21 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20150344575 - Koenig; Scott ; et al. | 2015-12-03 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20150344574 - Koenig; Scott ; et al. | 2015-12-03 |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
Grant 9,056,906 - Koenig , et al. June 16, 2 | 2015-06-16 |
Mobile device case with retractor reel assembly for user-provided headphones
Grant 9,049,782 - Koenig , et al. June 2, 2 | 2015-06-02 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,968,730 - Koenig , et al. March 3, 2 | 2015-03-03 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,946,387 - Koenig , et al. February 3, 2 | 2015-02-03 |
Mobile Device Case With Retractor Reel Assembly For User-provided Headphones
App 20140311792 - KOENIG; Scott ; et al. | 2014-10-23 |
Bispecific Molecules That Are Immunoreactive with Immune Effector Cells of a Companion Animal That Express an Activating Receptor and Cells That Express B7-H3 and Uses Thereof
App 20140255407 - Koenig; Scott | 2014-09-11 |
Mobile device case with retractor reel assembly for user-provided headphones
Grant 8,800,907 - Koenig , et al. August 12, 2 | 2014-08-12 |
Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting
App 20140134162 - Stavenhagen; Jeffrey B. ; et al. | 2014-05-15 |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
Grant 8,663,634 - Koenig , et al. March 4, 2 | 2014-03-04 |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting
Grant 8,652,466 - Stavenhagen , et al. February 18, 2 | 2014-02-18 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,530,627 - Koenig , et al. September 10, 2 | 2013-09-10 |
Mobile Device Case with Retractor Reel Assembly for User-Provided Headphones
App 20130083456 - Koenig; Scott ; et al. | 2013-04-04 |
Engineering Fc Antibody Regions to Confer Effector Function
App 20120263711 - Stavenhagen; Jeffery ; et al. | 2012-10-18 |
Engineering Fc antibody regions to confer effector function
Grant 8,216,574 - Stavenhagen , et al. July 10, 2 | 2012-07-10 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,193,318 - Koenig , et al. June 5, 2 | 2012-06-05 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,187,593 - Koenig , et al. May 29, 2 | 2012-05-29 |
Methods Of Administering / Dosing Anti-rsv Antibodies For Prophylaxis And Treatment
App 20120070447 - YOUNG; JAMES F. ; et al. | 2012-03-22 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20120009186 - Koenig; Scott ; et al. | 2012-01-12 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,044,180 - Koenig , et al. October 25, 2 | 2011-10-25 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
Grant 7,847,082 - Young , et al. December 7, 2 | 2010-12-07 |
Engineering Fc Antibody Regions to Confer Effector Function
App 20100196362 - Stavenhagen; Jeffrey ; et al. | 2010-08-05 |
Methods Of Administering/dosing Anti-rsv Antibodies For Prophylaxis And Treatment
App 20100028948 - Young; James F. ; et al. | 2010-02-04 |
Methods For The Treatment Of Lada And Other Adult- Onset Autoimmune Using Immunosuppressive Monoclonal Antibodies With Reduced Toxicity
App 20100015142 - Koenig; Scott | 2010-01-21 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
Grant 7,635,568 - Young , et al. December 22, 2 | 2009-12-22 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
Grant 7,553,489 - Young , et al. June 30, 2 | 2009-06-30 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20090092610 - Koenig; Scott ; et al. | 2009-04-09 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20090076251 - Koenig; Scott ; et al. | 2009-03-19 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20090074771 - Koenig; Scott ; et al. | 2009-03-19 |
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
Grant 7,504,107 - Koenig March 17, 2 | 2009-03-17 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20090053218 - Koenig; Scott ; et al. | 2009-02-26 |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
Grant 7,479,282 - Tuomanen , et al. January 20, 2 | 2009-01-20 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20090017026 - Koenig; Scott ; et al. | 2009-01-15 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20090017023 - Koenig; Scott ; et al. | 2009-01-15 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20090017027 - Koenig; Scott ; et al. | 2009-01-15 |
Derivatives of choline binding proteins for vaccines
Grant 7,435,421 - Wizemann , et al. October 14, 2 | 2008-10-14 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 7,425,619 - Koenig , et al. September 16, 2 | 2008-09-16 |
Fc.gamma.RIIB-specific antibodies and methods of use thereof
Grant 7,425,620 - Koenig , et al. September 16, 2 | 2008-09-16 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
App 20080138349 - Stavenhagen; Jeffrey B. ; et al. | 2008-06-12 |
Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity
App 20080095766 - Koenig; Scott ; et al. | 2008-04-24 |
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
App 20080063649 - Koenig; Scott | 2008-03-13 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
Grant 7,323,172 - Young , et al. January 29, 2 | 2008-01-29 |
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
Grant 7,309,490 - Koenig December 18, 2 | 2007-12-18 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
App 20070196916 - Young; James F. ; et al. | 2007-08-23 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
Grant 7,229,619 - Young , et al. June 12, 2 | 2007-06-12 |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
App 20070077246 - Koenig; Scott ; et al. | 2007-04-05 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
Grant 7,179,900 - Young , et al. February 20, 2 | 2007-02-20 |
FcgammaRIIB-specific antibodies and methods of use thereof
App 20060177439 - Koenig; Scott ; et al. | 2006-08-10 |
Engineering Fc antibody regions to confer effector function
App 20060134709 - Stavenhagen; Jeffery ; et al. | 2006-06-22 |
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
App 20050276797 - Koenig, Scott | 2005-12-15 |
Fcgamma-RIIB-specific antibodies and methods of use thereof
App 20050260213 - Koenig, Scott ; et al. | 2005-11-24 |
Methods of priming the immunogenic activity of vaccines useful for eliciting a protective immune response
Grant 6,962,701 - Koenig November 8, 2 | 2005-11-08 |
Fcgamma riib specific antibodies and methods of use thereof
App 20050215767 - Koenig, Scott ; et al. | 2005-09-29 |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
App 20050208069 - Tuomanen, Elaine I. ; et al. | 2005-09-22 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
App 20050196749 - Young, James F. ; et al. | 2005-09-08 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
App 20050147616 - Young, James F. ; et al. | 2005-07-07 |
Derivatives of choline binding proteins for vaccines
App 20050142145 - Wizemann, Theresa M. ; et al. | 2005-06-30 |
Derivatives of choline binding proteins for vaccines
Grant 6,863,893 - Wizemann , et al. March 8, 2 | 2005-03-08 |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
Grant 6,858,706 - Tuomanen , et al. February 22, 2 | 2005-02-22 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
Grant 6,855,493 - Young , et al. February 15, 2 | 2005-02-15 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
App 20050002926 - Young, James F. ; et al. | 2005-01-06 |
Pneumococcal protein homologs and fragments for vaccines
Grant 6,833,356 - Koenig , et al. December 21, 2 | 2004-12-21 |
Anti-RSV antibodies
Grant 6,818,216 - Young , et al. November 16, 2 | 2004-11-16 |
FcgammaRIIB-specific antibodies and methods of use thereof
App 20040185045 - Koenig, Scott ; et al. | 2004-09-23 |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
App 20040120966 - Tuomanen, Elaine I. ; et al. | 2004-06-24 |
Immunogenic pneumococcal protein and vaccine compositions thereof
Grant 6,689,369 - Koenig , et al. February 10, 2 | 2004-02-10 |
Methods of enhancing activity of vaccines and vaccine compositions
App 20030206907 - Koenig, Scott | 2003-11-06 |
Immunogenic pneumococcal protein and vaccine compositions thereof
App 20030166844 - Koenig, Scott ; et al. | 2003-09-04 |
Derivatives of choline binding proteins for vaccines
App 20030138447 - Wizemann, Theresa M. ; et al. | 2003-07-24 |
A Polypeptide Comprising The Amino Acid Of An N-terminal Choline Binding Protein A Truncate, Vaccine Derived Therefrom And Uses Thereof
App 20030096950 - TUOMANEN, ELAINE I. ; et al. | 2003-05-22 |
Methods of enhancing activity of vaccines and vaccine compositions
Grant 6,565,849 - Koenig May 20, 2 | 2003-05-20 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
App 20030091584 - Young, James F. ; et al. | 2003-05-15 |
Derivatives of choline binding proteins for vaccines
Grant 6,503,511 - Wizemann , et al. January 7, 2 | 2003-01-07 |
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
App 20020177126 - Young, James F. ; et al. | 2002-11-28 |
Caulobacter LPS immunoadjuvants
Grant 6,368,599 - Langermann , et al. April 9, 2 | 2002-04-09 |
Epitope-based vaccine for respiratory syncytial virus F-protein
App 20020018780 - Koenig, Scott ; et al. | 2002-02-14 |
Antibody gene therapy with adeno-associated viral vectors
App 20010034062 - Koenig, Scott | 2001-10-25 |
Methods of enhancing activity of vaccines and vaccine compositions
App 20010026798 - Koenig, Scott | 2001-10-04 |
| 